The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews
- PMID: 20156912
- DOI: 10.1136/bmj.c365
The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews
Abstract
Objective: To examine the prevalence of outcome reporting bias-the selection for publication of a subset of the original recorded outcome variables on the basis of the results-and its impact on Cochrane reviews.
Design: A nine point classification system for missing outcome data in randomised trials was developed and applied to the trials assessed in a large, unselected cohort of Cochrane systematic reviews. Researchers who conducted the trials were contacted and the reason sought for the non-reporting of data. A sensitivity analysis was undertaken to assess the impact of outcome reporting bias on reviews that included a single meta-analysis of the review primary outcome.
Results: More than half (157/283 (55%)) the reviews did not include full data for the review primary outcome of interest from all eligible trials. The median amount of review outcome data missing for any reason was 10%, whereas 50% or more of the potential data were missing in 70 (25%) reviews. It was clear from the publications for 155 (6%) of the 2486 assessable trials that the researchers had measured and analysed the review primary outcome but did not report or only partially reported the results. For reports that did not mention the review primary outcome, our classification regarding the presence of outcome reporting bias was shown to have a sensitivity of 88% (95% CI 65% to 100%) and specificity of 80% (95% CI 69% to 90%) on the basis of responses from 62 trialists. A third of Cochrane reviews (96/283 (34%)) contained at least one trial with high suspicion of outcome reporting bias for the review primary outcome. In a sensitivity analysis undertaken for 81 reviews with a single meta-analysis of the primary outcome of interest, the treatment effect estimate was reduced by 20% or more in 19 (23%). Of the 42 meta-analyses with a statistically significant result only, eight (19%) became non-significant after adjustment for outcome reporting bias and 11 (26%) would have overestimated the treatment effect by 20% or more.
Conclusions: Outcome reporting bias is an under-recognised problem that affects the conclusions in a substantial proportion of Cochrane reviews. Individuals conducting systematic reviews need to address explicitly the issue of missing outcome data for their review to be considered a reliable source of evidence. Extra care is required during data extraction, reviewers should identify when a trial reports that an outcome was measured but no results were reported or events observed, and contact with trialists should be encouraged.
Comment in
-
Do systematic reviews still exclude studies with "no relevant outcome data"?BMJ. 2017 Aug 21;358:j3919. doi: 10.1136/bmj.j3919. BMJ. 2017. PMID: 28827402 No abstract available.
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions.Cochrane Database Syst Rev. 2014 Oct 1;2014(10):MR000035. doi: 10.1002/14651858.MR000035.pub2. Cochrane Database Syst Rev. 2014. PMID: 25271098 Free PMC article.
-
Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews.BMJ. 2014 Nov 21;349:g6501. doi: 10.1136/bmj.g6501. BMJ. 2014. PMID: 25416499 Free PMC article.
-
Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.Cochrane Database Syst Rev. 2014 Apr 29;2014(4):MR000034. doi: 10.1002/14651858.MR000034.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2024 Jan 4;1:MR000034. doi: 10.1002/14651858.MR000034.pub3. PMID: 24782322 Free PMC article. Updated.
Cited by
-
Lacosamide add-on therapy for focal epilepsy.Cochrane Database Syst Rev. 2021 May 17;5(5):CD008841. doi: 10.1002/14651858.CD008841.pub3. Cochrane Database Syst Rev. 2021. PMID: 33998660 Free PMC article.
-
Protocol of the Development of a Core Outcome Set for Ischemic Stroke in Clinical Trials of Chinese Medicine.Evid Based Complement Alternat Med. 2020 Oct 3;2020:2649843. doi: 10.1155/2020/2649843. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33082820 Free PMC article.
-
Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study.BMJ. 2012 Aug 16;345:e5155. doi: 10.1136/bmj.e5155. BMJ. 2012. PMID: 22906823 Free PMC article.
-
Selective reporting of outcomes in randomised controlled trials in systematic reviews of cystic fibrosis.BMJ Open. 2013 Jun 20;3(6):e002709. doi: 10.1136/bmjopen-2013-002709. BMJ Open. 2013. PMID: 23794538 Free PMC article.
-
Sjogren's syndrome in clinical trials of traditional Chinese medicine: protocol for the development of a core outcome set.Trials. 2021 Mar 26;22(1):233. doi: 10.1186/s13063-021-05187-8. Trials. 2021. PMID: 33771203 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources